Optical biosensors for diagnosis of COVID-19: nanomaterial-enabled particle strategies for post pandemic era.
Yusuf Samil TekinSeyda Mihriban KulOsman SagdicNadnudda RodthongkumBrian GeissTugba OzerPublished in: Mikrochimica acta (2024)
The COVID-19 pandemic underlines the need for effective strategies for controlling virus spread and ensuring sensitive detection of SARS-CoV-2. This review presents the potential of nanomaterial-enabled optical biosensors for rapid and low-cost detection of SARS-CoV-2 biomarkers, demonstrating a comprehensive analysis including colorimetric, fluorescence, surface-enhanced Raman scattering, and surface plasmon resonance detection methods. Nanomaterials including metal-based nanomaterials, metal-organic frame-based nanoparticles, nanorods, nanoporous materials, nanoshell materials, and magnetic nanoparticles employed in the production of optical biosensors are presented in detail. This review also discusses the detection principles, fabrication methods, nanomaterial synthesis, and their applications for the detection of SARS-CoV-2 in four categories: antibody-based, antigen-based, nucleic acid-based, and aptamer-based biosensors. This critical review includes reports published in the literature between the years 2021 and 2024. In addition, the review offers critical insights into optical nanobiosensors for the diagnosis of COVID-19. The integration of artificial intelligence and machine learning technologies with optical nanomaterial-enabled biosensors is proposed to improve the efficiency of optical diagnostic systems for future pandemic scenarios.
Keyphrases
- sars cov
- loop mediated isothermal amplification
- sensitive detection
- label free
- artificial intelligence
- high resolution
- machine learning
- respiratory syndrome coronavirus
- high speed
- coronavirus disease
- low cost
- magnetic nanoparticles
- nucleic acid
- real time pcr
- gold nanoparticles
- big data
- quantum dots
- systematic review
- deep learning
- randomized controlled trial
- climate change
- emergency department
- current status
- reduced graphene oxide
- electronic health record